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Introduction 
Cardiac monitoring was initially employed in coronary care 
units during the 1950s and 1960s. Today, it is more broadly 
applied in a variety of critical and noncritical care hospital 
settings. Although cardiac monitoring is required by the 
Joint Commission on Hospital Accreditation (1) in all critical 
care areas, it now is being used more frequently in noncrit-
ical care settings to improve patient care, reduce medico-
legal risk and serve as a laborsaving device. 
Despite nearly 30 years of in-hospital use of cardiac 
monitoring, only a few studies (2-9) have attempted to define 
its value and limitations. Most of those reports are of little 
relevance today, as newer, more specific and accurate 
arrhythmia recognition and alarm technology replaces ear-
lier systems that were based on heart rate. In light of the 
expanding use of this technology, this document was devel-
oped for the American College of Cardiology by the Emer-
gency Cardiac Care (ACC/ECC) Committee to provide 
guidelines for the application of in-hospital cardiac monitor-
ing. Although such monitoring is often used to reduce 
medicolegal risk or as a laborsaving device, or both, the 
criteria proposed herein reflect medical rather than eco-
nomic or personnel considerations. 
Pro~ess Used for Development of Guidelines 
The method used to develop these guidelines was similar 
to that of a combined American College of Cardiology and 
American Heart Association Task Force that recently devel-
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oped guidelines for ambulatory electrocardiography (10). A 
draft document was prepared by the ACC/ECC Committee 
with consultation from the ACC Committee on Electrophys-
iology and the ACC Committee on Technology. The com-
mittee membership at large reviewed, modified and ap-
proved the document. Officers and other responsible 
individuals in the American College of Cardiology reviewed, 
modified and approved the final document. 
Because many different recording and analysis systems 
are in clinical use throughout the United States today, this 
document assumes that any cardiac monitoring system to 
which these guidelines apply accurately records, retrieves 
and displays cardiac electrical signals. These guidelines are 
intended to cover the use of in-hospital hard-wire and 
telemetry cardiac rhythm monitoring systems. They do not 
pertain to other forms of cardiac monitoring such as ambu-
latory electrocardiographic (ECG) (Holter) or ST segment 
monitoring devices used to detect myocardial ischemia. 
The role of cardiac monitoring has changed dramatically 
in the last several years, and will continue to change. Future 
advances in technology and socioeconomic factors (e.g., 
shortages of nurses, hospital budgetary constraints, health 
care reimbursement procedures) will continue to influence 
the availability of cardiac monitoring and its subsequent use 
by the clinician. The American College of Cardiology recog-
nizes that no set of guidelines can anticipate all possible 
clinical situations. Accordingly, the ultimate judgment re-
garding the use of any specific procedures or diagnostic tests 
remains the responsibility of the patient's physician or 
physicians. 
General Guidelines 
The following guidelines apply to the use of cardiac 
monitoring in all clinical settings: 
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1. There must be adequate human surveillance of the 
monitors 24 hours a day by medical, nursing or paramedical 
personnel (monitor watchers) trained and qualified in the 
ECG recognition of clinically significant cardiac rhythm 
disturbances. In general, the degree of human surveillance 
required is inversely related to the sophistication and reli-
ability of the cardiac monitoring equipment used. 
2. Appropriately trained physicians and nurses must be 
responsible for decisions regarding the use of cardiac mon-
itoring in each hospital clinical area with these devices in 
use. These individuals must determine: a) the specific degree 
of monitoring surveillance that is appropriate for each clin-
ical area; b) the minimal qualification and training standards 
of personnel assigned to monitor surveillance duties; c) the 
protocols and procedures for responding to common ar-
rhythmias; d) the unit-specific indications for initiation and 
discontinuation of cardiac monitoring. 
3. Adequate numbers of trained medical personnel (phy-
sicians or nurses, or both) must be present or immediately 
available to treat important, life-threatening arrhythmias 
detected by the system. The lack of available personnel to 
promptly detect or treat arrhythmias expeditiously should 
raise questions concerning the indications for surveillance. 
Clinical Indications for Cardiac Monitoring 
No published clinical studies have established firm crite-
ria for in-hospital cardiac monitoring. Accordingly, the fol-
lowing rating system was devised by the ACC-ECC Com-
mittee to classify the more common clinical conditions for 
which such monitoring is currently being applied. Assign-
ment of common clinical situations to each of the categories 
in this document reflects the opinions of the ACC-ECC 
members. 
Class I. Cardiac monitoring is indicated in most if not all 
such patients. 
Class II. Cardiac monitoring may be of benefit in some 
patients but is not considered essential for all. 
Class III. Cardiac monitoring is not indicated because the 
patient's risk of a serious arrhythmia is so low that monitor-
ing is not of therapeutic benefit. 
The ACC recognizes that, given the diversity of uses for 
cardiac monitoring, a comprehensive listing of the precise 
usefulness of monitoring in every clinical situation is impos-
sible. There may be situations in which a patient in a class I 
category may not desire or require monitoring and other 
circumstances in which a patient in class III may be appro-
priate for cardiac monitoring because of the complexity of 
managing his or her medical problems. The period of time 
that cardiac monitoring serves a clinically useful purpose is 
highly variable and must be individualized by the clinician to 
meet each specific patient's needs. The guidelines are in-
tended to begin to define the medical indications for in-
hospital cardiac monitoring. They were not developed for 
use as guidelines for reimbursement, medicolegal consider-
ations, quality assurance or the definition of when monitor-
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ing can or should be used to substitute for medical or nursing 
personnel, or both. Such considerations are important but 
are beyond the scope of this document. 
Guidelines classifying the use of cardiac monitoring for a 
variety of common clinical situations follow: 
Class I 
Cardiac monitoring is indicated in most if not all patients 
in this group. This category includes all patients who are at 
significant risk of an immediate, life-threatening arrhythmia. 
I. Early hospital phase (from arrival in the emergency 
department through the lst 3 days) of patients with initially 
suspected and subsequently proved acute myocardial infarc-
tion. This period will be longer for patients with clinically 
important complications (e.g., significant arrhythmias, con-
duction defects, silent ischemia, pump failure, shock). In 
general, patients with such complications need to be moni-
tored for 22 days after the complication has been corrected 
or controlled (see class II). 
2. Patients suspected of having acute myocardial infarc-
tion on the basis of clinical or ECG criteria, or both. 
Monitoring is continued until infarction can be excluded. 
3. During surgery and early convalescence (postoperative 
care unit period and for the I st 3 days) of all patients who 
have undergone cardiac surgery, including those who re-
ceive an automated internal cardioverter defibrillation (lCD) 
system. This period will be longer for patients with clinically 
important complications (e.g., significant arrhythmias, seri-
ous conduction defects, pump failure, shock). In general, 
patients with such complications need to be monitored for 
22 days after the problem has been corrected or controlled. 
4. Patients who have been resuscitated recently from 
cardiac arrest or those documented directly or indirectly to 
be at risk for cardiac arrest (e.g., patients with Mobitz type 
II heart block or greater, new onset high degree heart block, 
runs of sustained ventricular tachycardia or new onset 
intraventricular conduction defects. 
5. Most critically ill medical or surgical patients requiring 
care in intensive care units. This group includes, but is not 
limited to, those patients who are in hemodynamically 
unstable condition or who are undergoing mechanical ven-
tilation. 
6. During the acute phase of management of patients who 
have been poisoned with drugs or chemicals at doses known 
or suspected to have cardiac arrhythmic toxicity (e.g., 
tricyclic antidepressants, phenothiazines, digitalis, antiar-
rhythmic drugs). 
7. During the acute phase of myocarditis. 
8. During initiation and loading of type I or type III 
antiarrhythmic drugs for potentially life-threatening arrhyth-
mias in patients clinically prone to proarrhythmic effects. 
9. Immediately after percutaneous transluminal coronary 
angioplasty for patients with complications of the procedure 
(e.g., coronary artery dissection or thrombosis). Monitoring 
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should continue until the patient's condition has been stable 
for at least 24 h. 
10. Patients with unstable angina; monitoring is continued 
until the patients is in stable condition (not necessarily pain 
free). 
11. Patients with high risk coronary artery lesions (e.g., 
high grade left main coronary artery disease or its equiva-
lent) who are candidates for, and who will undergo, urgent 
mechanical revascularization. 
12. Patients treated for arrhythmias by catheter ablation. 
Class II 
Cardiac monitoring may be of benefit in some patients but 
is not essential for all. 
1. Patients with acute myocardial infarction after day 3, 
especially those suspected to be at higher risk for ventricular 
fibrillation such as those with anterior wall Q wave infarc-
tion, conduction defects or the complications of infarction 
indicated in class I-1. Patients with no complications, non-
transmural events or nonanterior wall infarction are at lower 
risk. 
2. Patients with potentially lethal arrhythmias several 
days after initial control of the arrhythmia. 
3. Patients who, because of their underlying disease state, 
are deemed by the physician to be at significant risk for 
cardiac arrest, respiratory arrest or the development of 
hypotension. 
4. Patients with clinically significant nonlife-threatening 
arrhythmias (e.g., atrial fibrillation) who, because of severe 
underlying cardiac dysfunction, are considered to be at 
increased risk for proarrhythmic effects during initial treat-
ment with a Type I or a Type III antiarrhythmic agent. 
5. Patients with suspected or proved hemodynamically 
significant paroxysmal tachyarrhythmias or bradyarrhyth-
mias. 
6. During the acute phase of pericarditis when myocardi-
tis is not clinically evident. 
7. Patients who are being evaluated for unexplained 
syncope or other transient neurologic signs or symptoms 
that might be due to a cardiac arrhythmia. 
8. Immediately after percutaneous transluminal coronary 
angioplasty. 
9. During the 1st 48 to 72 h, patients in whom a permanent 
pacemaker and lead system has been implanted. 
10. Patients in stable condition after cardiac surgery. 
Class III 
Cardiac monitoring is not indicated because the patient's 
risk of,a serious arrhythmia or the likelihood of therapeutic 
benefit is low. 
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1. Postoperative patients who are at low risk, such as 
young patients after relatively simple uncomplicated opera-
tions that do not involve cardiopulmonary bypass. 
2. Obstetric patients, except for those with significant 
medical (especially cardiovascular) conditions or those who 
develop the cardiovascular difficulties defined in class I or II. 
3. Patients who have a terminal illness and who are not 
candidates for the treatment of arrhythmias that may be 
detected. Many, but not necessarily all patients with a "do 
not resuscitate" designation may fit into this category. 
4. Patients who have undergone routine, uncomplicated 
coronary angiography. 
5. Patients with chronic, stable atrial fibrillation. 
6. Patients with stable asymptomatic premature ventric-
ular contractions or nonsustained ventricular tachycardia 
who are hospitalized for reasons other than cardiac or 
hemodynamic compromise. 
7. Patients whose underlying cardiac disease has been 
stabilized and who have had no arrhythmias on 3 consecu-
tive days of monitoring. 
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